Olema Pharmaceuticals's total assets for Q4 2025 were $533.43M, an increase of 51.35% from the previous quarter. OLMA total liabilities were $54.87M for the fiscal quarter, a 22.03% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.